Tissue-specific tolerance in fatal Covid-19
ABSTRACT Background Tissue inflammation is associated with organ dysfunction and death in Covid-19. The efficacy of dexamethasone in preventing mortality in critical Covid-19 suggests that inflammation has a causal role in death. Whether this deleterious inflammation is a direct response to the presence of SARS-CoV-2, or an independent immuno-pathologic process, is unknown.Methods Tissue was acquired from detailed post-mortem examinations conducted on 11 well characterised hospitalised patients with fatal Covid-19. SARS-CoV-2 organotropism was mapped at an organ level by multiplex PCR and sequencing, with cellular resolution achieved by in situ viral spike (S) protein detection. Histological evidence of inflammation and organ injury was systematically examined, and the pulmonary immune response characterized with multiplex immunofluorescence.Findings SARS-CoV-2 was detected across a wide variety of organs, most frequently in the respiratory tract but also in numerous extra-pulmonary sites. Minimal histological evidence of inflammation was identified in non-pulmonary organs despite frequent detection of viral RNA and protein. At a cellular level, viral protein was identified without adjacent inflammation in the intestine, liver and kidney. Severe inflammatory change was restricted to the lung and reticulo-endothelial system. Diffuse alveolar damage, pulmonary thrombi and a monocyte/myeloid-predominant vasculitis were the predominant pulmonary findings, though there was not a consistent association between viral presence and either the presence or nature of the inflammatory response within the lung. Immunophenotyping revealed an influx of macrophages, monocytes and T cells into pulmonary parenchyma. Bone marrow examination revealed plasmacytosis, erythroid dysplasia and iron-laden macrophages. Plasma cell excess was also present in lymph node, spleen and lung. These stereotyped reticulo-endothelial responses occurred largely independently of the presence of virus in lymphoid tissues.Conclusions Tissue inflammation and organ dysfunction in fatal Covid-19 do not map to the tissue and cellular distribution of SARS-CoV-2, demonstrating tissue-specific tolerance. We conclude that death in Covid-19 is primarily a consequence of immune-mediated, rather than pathogen-mediated, organ inflammation and injury.Funding The Chief Scientist Office, LifeArc, Medical Research Scotland, UKRI (MRC)..
| Medienart: |
|
|---|
Preprint| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
bioRxiv.org - (2021) vom: 03. Feb. Zur Gesamtaufnahme - year:2021 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dorward, David A [VerfasserIn] |
|---|
| Links: |
|---|
| doi: |
10.1101/2020.07.02.20145003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
XBI018283446 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | XBI018283446 | ||
| 003 | DE-627 | ||
| 005 | 20230429093959.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200706s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1101/2020.07.02.20145003 |2 doi | |
| 035 | |a (DE-627)XBI018283446 | ||
| 035 | |a (DE-599)biorXiv10.1101/2020.07.02.20145003 | ||
| 035 | |a (biorXiv)10.1101/2020.07.02.20145003 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 570 |q DE-84 | |
| 100 | 1 | |a Dorward, David A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Tissue-specific tolerance in fatal Covid-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a ABSTRACT Background Tissue inflammation is associated with organ dysfunction and death in Covid-19. The efficacy of dexamethasone in preventing mortality in critical Covid-19 suggests that inflammation has a causal role in death. Whether this deleterious inflammation is a direct response to the presence of SARS-CoV-2, or an independent immuno-pathologic process, is unknown.Methods Tissue was acquired from detailed post-mortem examinations conducted on 11 well characterised hospitalised patients with fatal Covid-19. SARS-CoV-2 organotropism was mapped at an organ level by multiplex PCR and sequencing, with cellular resolution achieved by in situ viral spike (S) protein detection. Histological evidence of inflammation and organ injury was systematically examined, and the pulmonary immune response characterized with multiplex immunofluorescence.Findings SARS-CoV-2 was detected across a wide variety of organs, most frequently in the respiratory tract but also in numerous extra-pulmonary sites. Minimal histological evidence of inflammation was identified in non-pulmonary organs despite frequent detection of viral RNA and protein. At a cellular level, viral protein was identified without adjacent inflammation in the intestine, liver and kidney. Severe inflammatory change was restricted to the lung and reticulo-endothelial system. Diffuse alveolar damage, pulmonary thrombi and a monocyte/myeloid-predominant vasculitis were the predominant pulmonary findings, though there was not a consistent association between viral presence and either the presence or nature of the inflammatory response within the lung. Immunophenotyping revealed an influx of macrophages, monocytes and T cells into pulmonary parenchyma. Bone marrow examination revealed plasmacytosis, erythroid dysplasia and iron-laden macrophages. Plasma cell excess was also present in lymph node, spleen and lung. These stereotyped reticulo-endothelial responses occurred largely independently of the presence of virus in lymphoid tissues.Conclusions Tissue inflammation and organ dysfunction in fatal Covid-19 do not map to the tissue and cellular distribution of SARS-CoV-2, demonstrating tissue-specific tolerance. We conclude that death in Covid-19 is primarily a consequence of immune-mediated, rather than pathogen-mediated, organ inflammation and injury.Funding The Chief Scientist Office, LifeArc, Medical Research Scotland, UKRI (MRC). | ||
| 700 | 1 | |a Russell, Clark D |e verfasserin |4 aut | |
| 700 | 1 | |a Um, In Hwa |e verfasserin |4 aut | |
| 700 | 1 | |a Elshani, Mustafa |e verfasserin |4 aut | |
| 700 | 1 | |a Armstrong, Stuart D |e verfasserin |4 aut | |
| 700 | 1 | |a Penrice-Randal, Rebekah |e verfasserin |4 aut | |
| 700 | 1 | |a Millar, Tracey |e verfasserin |4 aut | |
| 700 | 1 | |a Lerpiniere, Chris EB |e verfasserin |4 aut | |
| 700 | 1 | |a Tagliavini, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Hartley, Catherine S |e verfasserin |4 aut | |
| 700 | 1 | |a Randle, Nadine P |e verfasserin |4 aut | |
| 700 | 1 | |a Gachanja, Naomi N |e verfasserin |4 aut | |
| 700 | 1 | |a Potey, Philippe MD |e verfasserin |4 aut | |
| 700 | 1 | |a Anderson, Alison M |e verfasserin |4 aut | |
| 700 | 1 | |a Campbell, Victoria L |e verfasserin |4 aut | |
| 700 | 1 | |a Duguid, Alasdair J |e verfasserin |4 aut | |
| 700 | 1 | |a Qsous, Wael Al |e verfasserin |4 aut | |
| 700 | 1 | |a BouHaidar, Ralph |e verfasserin |4 aut | |
| 700 | 1 | |a Baillie, J Kenneth |e verfasserin |4 aut | |
| 700 | 1 | |a Dhaliwal, Kevin |e verfasserin |4 aut | |
| 700 | 1 | |a Wallace, William A |e verfasserin |4 aut | |
| 700 | 1 | |a Bellamy, Christopher OC |e verfasserin |4 aut | |
| 700 | 1 | |a Prost, Sandrine |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Colin |e verfasserin |4 aut | |
| 700 | 1 | |a Hiscox, Julian A |e verfasserin |4 aut | |
| 700 | 1 | |a Harrison, David J |e verfasserin |4 aut | |
| 700 | 1 | |a Lucas, Christopher D |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2021) vom: 03. Feb. |
| 773 | 1 | 8 | |g year:2021 |g day:03 |g month:02 |
| 856 | 4 | 0 | |u https://doi.org/10.1164/rccm.202008-3265OC |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.07.02.20145003 |z kostenfrei |3 Volltext |
| 912 | |a GBV_XBI | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |j 2021 |b 03 |c 02 | ||
| 953 | |2 045F |a 570 | ||